type here...

CATEGORIES

Medication

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Does Botox Drop Anxiety?

Michael Hunter, MD -
WITH DISEASE SPREAD AND DEATHS, large outbreaks of Covid-19 infection are associated with fear and grief. I don't know about you, but the limits on...

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne -
Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD -
The psychological effects of public space shootings extend beyond physical harm because they create a broad psychological impact on everyone present at the scene....

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories